|
V.A. Bulgakova
POTENTIALS FOR THE INCREASING THE EFFECTIVENESS OF TREATMENT OF VIRUS-INDUCED BRONCHIAL ASTHMA IN CHILDREN
|
6-12 |
|
S.A. Karpishchenko, O.M. Kolesnikova
CHRONIC TONSILLITIS: UNDERSTANDING OF THE MICROBIAL LANDSCAPE OF THE TONSILS
|
13-17 |
|
A.A. Zajcev, A.V. Bezlepko, A.I. Sinopal'nikov
DIAGNOSIS AND PHARMACOTHERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: BASIC PROVISIONS
|
18-24 |
|
G.P. Martynova, I.A.Solovyeva, A.G.Yuzhakova
ROTAVIRUS INFECTION IN CHILDREN
|
25-30 |
|
A.A. Zajcev, A.V. Vlasova
CURRENT ISSUES IN THE PHARMACOTHERAPY OF ACUTE RESPIRATORY VIRAL INFECTIONS
|
31-35 |
|
O.N. Barkanova, S.G. Gagarina, AA Kaluzhenina, N.L. Popkova
DIAGNOSIS AND TREATMENT OF TUBERCULOSIS IN PEOPLE INFECTED WITH HIV
|
36-41 |
|
N.M. Nenasheva
TREATMENT OF BRONCHIAL ASTHMA ACCORDING TO THE MODERN NATIONAL AND INTERNATIONAL GUIDELINES
|
42-48 |
|
O.I. Simonova, Ju.V. Gorinova
MUCOLYTIC THERAPY ALGORITHM: WHAT A PEDIATRICIAN SHOULD KEEP IN MIND
|
49-54 |
|
D.Yu. Ovsyannikov, MD, A.M. Bolibok
PROPHYLAXIS AND THERAPY OF BRONCHOPULMONARY DYSPLASIA: WHAT IS THE BASE OF EVIDENCE OF EFFECTIVENESS?
|
55-60 |
|
V.I. Trofimov
GLUCOCORTICOIDS - THE GOLD STANDARD FOR BRONCHIAL ASTHMA TREATMENT
|
61-64 |
|
S.A. Bozhkova, E.M. Polyakova, A.M. Borisov, A.N. Rukina
MRSA IN PROSTHETIC JOINT INFECTION: TARGET FOR THE ANTIBIOTIC THERAPY
|
65-69 |
|
D.V. Bestaev
LUNG DIFFUSION CAPACITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE
|
70-72 |
|
L.N. Mazankova (1), T.A. Chebotareva (1), I.D. Maykova (2), S.G. Gorbunov (1)
CYTOKINE STATUS AND EFFICIENCY OF CYTOKINE THERAPY OF ROTAVIRUS INFECTION IN CHILDREN
|
73-77 |
|
E.L. Savlevich, PhD in Medical Sciences
PATHOGENETIC RATIONALE FOR IMMUNOTHERAPY OF CHRONIC TONSILLITIS
|
78-81 |
|
N.A. Geppe, I.V. Ozerskaya
PLACE OF INHALED STEROIDS IN THE THERAPY OF BRONCHIAL ASTHMA IN CHILDREN OF DIFFERENT AGES
|
82-87 |
Русский
